ImpriMed, Inc. vs Tempus AI

ImpriMed, Inc. logo

ImpriMed, Inc.

AI-driven Personalized Medicine for Cancer Care

46 employees · est. 2017 · Mountain View, United States

VS
Tempus AI logo

Tempus AI

Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precision medicine

3178 employees · est. 2015 · Chicago, United States

Tempus AI is the older company (2017 vs 2015); Tempus AI is the larger of the two.

Side-by-Side Comparison

ImpriMed, Inc. Tempus AI
Founded
2017 2015 older
Headquarters
Mountain View, United States Chicago, United States
Employees
46 3178 larger
Industry
AI, Biotechnology, Machine Learning AI, Biotechnology, Health Care
Funding Stage
Series A Post-IPO Debt
Total Funding
$30.01B $1.64B
Funding Rounds
6 15
Services
Not tracked yet AI-Enabled Healthcare Solutions, Diagnostic Tools Development, Healthcare Data Analytics, Research Program Partnerships
Target Customers
Not tracked yet Healthcare Providers, Research Institutions, Medical Professionals, Healthcare Researchers
Taxonomy
Personalized MedicineCancer CareAI-driven HealthcareVeterinary OncologyBlood CancerPredictive Analysis +9 Precision MedicineMultimodal DataClinical Data InterpretationMolecular Data AnalysisPersonalized Patient CareTherapeutics Development +5
Website
imprimedicine.com tempus.com
ImpriMed, Inc. logo

About ImpriMed, Inc.

ImpriMed, Inc., a Silicon Valley-based startup founded in 2017, is at the forefront of precision medicine with its focus on AI-driven personalized cancer care. The company’s slogan, "AI-driven Personalized Medicine for Cancer Care", perfectly encapsulates its mission to revolutionize oncology treatm...

Tempus AI logo

About Tempus AI

Tempus AI, Inc. (NASDAQ: TEM) is at the forefront of integrating artificial intelligence into the healthcare sector, emphasizing the power of precision medicine. Since its founding in 2015, Tempus has focused on building one of the largest libraries of multimodal medical data globally, ensuring that...

Also comparing in this category

Comparing more than these two?

Get ImpriMed, Inc., Tempus AI and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does ImpriMed, Inc. compare?

A PDF of ImpriMed, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

ImpriMed, Inc. was founded in 2017, based in Mountain View, United States, with 46 employees. ImpriMed, Inc., a Silicon Valley-based startup founded in 2017, is at the forefront of precision medicine with its focus on AI-driven personalized cancer care. The company’s slogan, "AI-driven Persona. Tempus AI was founded in 2015, based in Chicago, United States, with 3,178 employees. Tempus AI, Inc. (NASDAQ: TEM) is at the forefront of integrating artificial intelligence into the healthcare sector, emphasizing the power of precision medicine. Since its founding in 2015, Tempus has.
ImpriMed, Inc. has raised $30.01B and Tempus AI $1.64B. Latest stage: ImpriMed, Inc. Series A, Tempus AI Post-IPO Debt.
Both work in AI, Biotechnology and Machine Learning.

Compare ImpriMed, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ImpriMed, Inc. on 12 Sep 2024, and Tempus AI on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes